StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Raised to $202 at RBC Capital
April 27, 2018 9:01 AM
RBC Capital raised its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Vertex (VRTX) PT Lowered to $175 at Leerink Partners
April 27, 2018 7:03 AM
Vertex Pharma (VRTX) Begins Phase 3 Studies of VX-445, Tezacaftor and Ivacaftor as Triple Combination Regimen for People with Cystic Fibrosis
April 26, 2018 4:37 PM
Form 8-K VERTEX PHARMACEUTICALS For: Apr 26
April 26, 2018 4:18 PM
Vertex Pharma (VRTX) Tops Q1 EPS by 14c; Reiterates Outlook
April 26, 2018 4:08 PM
